FFA
ARCT icon

Farther Finance Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Farther Finance Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76K Buy
555
+226
+69% +$1.78K ﹤0.01% 4935
2026
Q1 		$2.58K Buy
329
+39
+13% +$285 ﹤0.01% 4795
2025
Q4 		$1.78K Sell
290
-95
-25% -$1.03K ﹤0.01% 4738
2025
Q3 		$7.1K Buy
385
+121
+46% +$1.94K ﹤0.01% 3603
2025
Q2 		$3.44K Buy
+264
New +$3.12K ﹤0.01% 3513
2025
Q1 		– Sell
-47
Closed -$798 – 4273
2024
Q4 		$798 Sell
47
-23
-33% -$433 ﹤0.01% 3316
2024
Q3 		$1.63K Buy
70
+1
+1% +$21 ﹤0.01% 3069
2024
Q2 		$1.63K Buy
69
+18
+35% +$546 ﹤0.01% 2871
2024
Q1 		$1.69K Hold
51
– – ﹤0.01% 2556
2023
Q4 		$1.61K Buy
+51
New +$1.21K ﹤0.01% 2519

Other funds holding ARCT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's ARCT Position: Q2 2026 in Review

Farther Finance Advisors increased its Arcturus Therapeutics (ARCT) stake by 69% in Q2 2026, buying an estimated $1.78K and bringing the position to 555 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #4935.

Farther Finance Advisors first reported a position in ARCT in Q4 2023 and has held it in 10 quarters since. The position peaked at $7.1K in Q3 2025. 8 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Farther Finance Advisors held 555 shares of Arcturus Therapeutics worth $3.76K as of Q2 2026.
  • Farther Finance Advisors bought 226 Arcturus Therapeutics shares in Q2 2026, an estimated $1.78K.
  • Arcturus Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4935 holding.
  • Farther Finance Advisors first reported a position in Arcturus Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Farther Finance Advisors's Arcturus Therapeutics position peaked at $7.1K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.